Allogene Therapeutics, Inc. (ALLO) SEC Filings — 2024

Filings

• Pfizer to Acquire Allogene Therapeutics for $3.3 Billion — 8-K · Nov 13, 2024
• Allogene Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Allogene Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Allogene Therapeutics Files 8-K for Financials — 8-K · Nov 7, 2024
• Allogene Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 4, 2024
• Allogene Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Oct 22, 2024
• Allogene Therapeutics Files 8-K for Ethics Code, Exhibits — 8-K · Oct 7, 2024
• Allogene Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
• Allogene Therapeutics Announces CMO Departure, Board Changes — 8-K · Jun 10, 2024
• Allogene Therapeutics Enters Material Definitive Agreement — 8-K · May 31, 2024
• Allogene Therapeutics Files 8-K — 8-K · May 14, 2024
• Allogene Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Allogene Therapeutics Sets June 5th Virtual Annual Meeting — DEF 14A · Apr 23, 2024
• Allogene Therapeutics Files 10-K/A Amendment — 10-K/A · Mar 14, 2024
• Allogene Therapeutics Issues Non-Reliance on Past Financials — 8-K · Feb 16, 2024
• Allogene Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Allogene Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• FMR LLC & Abigail Johnson Hold 14.999% Stake in Allogene Therapeutics — SC 13G/A · Feb 9, 2024
• Allogene Therapeutics Enters Material Definitive Agreement — 8-K · Jan 31, 2024
• BlackRock Amends Allogene Therapeutics Stake, Remains Passive Investor — SC 13G/A · Jan 29, 2024
• State Street Exits Allogene Therapeutics Stake — SC 13G/A · Jan 23, 2024
• Allogene Therapeutics Reports Material Agreement, Exit Costs — 8-K · Jan 5, 2024